Nanotechnology for Drug Delivery and Pharmaceutical Sciences presents various drug-delivery techniques that utilize nanotechnology for the biomedical domain, highlighting both therapeutic and diagnostic applications. The book provides important facts and detailed studies on different promising nanocarriers like liposomes, exosomes and virus-based nanocarriers. Moreover, it explores these nanocarriers' utilization in the therapeutic applications of various diseases such as cancer, inflammation, neurodegenerative disorders like Huntington's disease, Alzheimer's disease, human immunodeficiency virus (HIV), and inflammatory bowel disease. In addition, the book describes how nanotechnology has efficiently overtaken conventional dosage forms and provided comfort and ease to patients.
Relevant information regarding market trends, patents and social-economic factors are also provided, making this the perfect reference for doctors, researchers and scientists working in the fields of medicine, biochemistry, biotechnology, nanobiotechnology and the pharmaceutical sciences.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Part 1: Targeted Drug Delivery1. Introduction to drug-delivery techniques based on nanotechnological approaches
2. Methods for fabricating various Nanocarriers for targeted drug delivery
3. Biologically synthesized nanocarriers for targeted drug delivery applications
4. Nanomedicine and Nanocarriers for Cancer treatment
5. Role of Nanocarriers for inflammation treatment
6. Nanocarriers and Nanomedicine for neurodegenerative disorders
7. Potentialities of Nanomedicine and Nanocarriers for infectious disease treatment
8. Utility of Nanomedicine and Nanocarriers for non-infectious disease treatment
9. Passive and active targeted drug delivery strategies
10. Utility of various drug delivery systems and their advantages and disadvantages
11. Clinical applications and future clinical trials of the drug delivery system
12. Advantages of nano-drug targeting than conventional dosage system
Part 2: Pharmaceuticals�
13. Role of nanotechnology in the pharmaceutical industry
14. Recent development in the pharmaceutical industries
15. Strategies to synthesize pharmaceutical nanoparticles
16. Biologically synthesized pharmaceutical nanoparticles
17. Advantages and disadvantages of pharmaceutical nanoparticles
18. Recent market trends of nano-based pharmaceutical products
19. Recent pharmaceutical patents based on nanotechnological aspects
20. Perspectives, safety issues, legal factors of nano-based materials utility in pharmaceutical applications
Authors
Ravindra Pratap Singh Assistant Professor, Indira Gandhi National Tribal University, India.Dr. Singh received his B. Sc. from Allahabad University India and his M.Sc and Ph.D. in Biochemistry from Lucknow University, India. He is currently working as an Assistant Professor in the Department of Biotechnology, Indira Gandhi National Tribal University, India. His work and research interests include biochemistry, biosensors, nanobiotechnology, electrochemistry, material sciences, and biosensors applications in biomedical, environmental, agricultural and forensics sciences.
Kshitij RB Singh Postgraduate, Kyushu Institute of Technology, Japan. Kshitij RB Singh obtained his MSc in Biotechnology from Indira Gandhi National Tribal University, India. Currently, he is a doctoral student in the laboratory of Professor Shyam S. Pandey at the Department of Life Science and Systems Engineering, Kyushu Institute of Technology, Japan. His research interests encompass a range of fields, including biotechnology, biochemistry, nanotechnology, nanobiotechnology, biosensors, and materials sciences. Jay Singh Assistant Professor, Banaras Hindu University, India.Dr. Jay is an Assistant Professor at the Department of Chemistry, Institute of Sciences, Banaras Hindu University, India, since 2017. He received his Ph.D. degree in Polymer Science from Motilal Nehru National Institute of Technology in 2010 and did MSc and BSc from Allahabad University, India. He is actively engaged in the development of nanomaterials (CeO2, NiO, rare-earth metal oxide, Ni, Nife2O4, Cu2O, Graphene, RGO etc.), based nanobiocomposite, conducting polymer and self-assembled monolayers based clinically important biosensors for estimation of bioanalaytes such as cholesterol, xanthine, glucose, pathogens and pesticides/toxins using DNA and antibodies. He is actively engaged in fabricating metal oxide-based biosensors for clinical diagnosis, food packaging applications, drug delivery, and tissue engineering applications.
Charles Oluwaseun Adetunji Full Professor at the Department of Microbiology, Faculty of Sciences and the Director of Research and Innovation, Edo State University Uzairue (EDSU), Edo State, Nigeria..Prof. Charles Oluwaseun Adetunji is a full Professor at the Department of Microbiology, Faculty of Sciences and the Director of Research and Innovation, Edo State University Uzairue (EDSU), Edo State, Nigeria. He formerly served as the Acting Director of Intellectual Property and Technology Transfer, Head of the Department of Microbiology, and Sub Dean of the Faculty of Science. Currently, he holds the positions of Chairman of the Grant Committee and Dean of the Faculty of Science at EDSU.
Prof. Adetunji is a Fellow of the Royal Society of Biology in the UK. Additionally, he serves as a Visiting Professor and the Executive Director of the Center for Biotechnology at Precious Cornerstone University, Nigeria. His research centers on applying biological techniques and microbial bioprocesses to achieve Sustainable Development Goals (SDGs) and contribute to advancements in agriculture.
